Health
Researchers develop novel class of cancer immunotherapy – Drug Target Review
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Posted: 30 October 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Researchers have developed a new type of cancer immunotherapy that uses nanobiologics to train the immune system to eliminate tumour cells. Nanobiologics are tiny materials bioengineered from natural molecules.
The lead candidate, called MTP10-HDL, was developed and tested on murine models…
Continue Reading
